181 related articles for article (PubMed ID: 1890207)
1. Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid.
Goldie J; Veldhuyzen van Zanten SJ; Jalali S; Richardson H; Hunt RH
J Clin Pathol; 1991 Aug; 44(8):695-7. PubMed ID: 1890207
[TBL] [Abstract][Full Text] [Related]
2. Urease production by Helicobacter (Campylobacter) pylori.
Vogt K; Hahn H
Zentralbl Bakteriol; 1991 Apr; 275(1):63-72. PubMed ID: 1930566
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of Helicobacter pylori urease: biochemical and ultrastructural analysis.
Nilius M; Bode G; Lehnhardt G; Malfertheiner P
Eur J Clin Invest; 1991 Oct; 21(5):551-7. PubMed ID: 1752295
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Helicobacter pylori urease activity by hydroxamic acid derivatives.
Odake S; Morikawa T; Tsuchiya M; Imamura L; Kobashi K
Biol Pharm Bull; 1994 Oct; 17(10):1329-32. PubMed ID: 7874052
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.
Ni WW; Liu Q; Ren SZ; Li WY; Yi LL; Jing H; Sheng LX; Wan Q; Zhong PF; Fang HL; Ouyang H; Xiao ZP; Zhu HL
Bioorg Med Chem; 2018 Aug; 26(14):4145-4152. PubMed ID: 29983280
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
[TBL] [Abstract][Full Text] [Related]
7. In Silico study of the active site of Helicobacter pylori urease and its inhibition by hydroxamic acids.
Arora R; Issar U; Kakkar R
J Mol Graph Model; 2018 Aug; 83():64-73. PubMed ID: 29775804
[TBL] [Abstract][Full Text] [Related]
8. Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors.
Li HQ; Xiao ZP; Yin-Luo ; Yan T; Lv PC; Zhu HL
Eur J Med Chem; 2009 May; 44(5):2246-51. PubMed ID: 18625539
[TBL] [Abstract][Full Text] [Related]
9. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects.
el Nujumi AM; Dorrian CA; Chittajallu RS; Neithercut WD; McColl KE
Gut; 1991 Aug; 32(8):866-70. PubMed ID: 1885067
[TBL] [Abstract][Full Text] [Related]
10. Significance of ammonia in the genesis of gastric epithelial lesions induced by Helicobacter pylori: an in vitro study with different bacterial strains and urea concentrations.
Sommi P; Ricci V; Fiocca R; Romano M; Ivey KJ; Cova E; Solcia E; Ventura U
Digestion; 1996; 57(5):299-304. PubMed ID: 8886572
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
Phillips K; Munster DJ; Allardyce RA; Bagshaw PF
J Clin Pathol; 1993 Apr; 46(4):372-3. PubMed ID: 8496397
[TBL] [Abstract][Full Text] [Related]
12. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.
Ohta T; Shibata H; Kawamori T; Iimuro M; Sugimura T; Wakabayashi K
Biochem Biophys Res Commun; 2001 Jul; 285(3):728-33. PubMed ID: 11453654
[TBL] [Abstract][Full Text] [Related]
13. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.
Liu Q; Shi WK; Ren SZ; Ni WW; Li WY; Chen HM; Liu P; Yuan J; He XS; Liu JJ; Cao P; Yang PZ; Xiao ZP; Zhu HL
Eur J Med Chem; 2018 Aug; 156():126-136. PubMed ID: 30006158
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
[TBL] [Abstract][Full Text] [Related]
15. Biological evaluation and molecular docking of baicalin and scutellarin as Helicobacter pylori urease inhibitors.
Yu XD; Zheng RB; Xie JH; Su JY; Huang XQ; Wang YH; Zheng YF; Mo ZZ; Wu XL; Wu DW; Liang YE; Zeng HF; Su ZR; Huang P
J Ethnopharmacol; 2015 Mar; 162():69-78. PubMed ID: 25557028
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid.
Zullo A; Rinaldi V; Hassan C; Folino S; Winn S; Pinto G; Attili AF
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):405-9. PubMed ID: 9789138
[TBL] [Abstract][Full Text] [Related]
17. Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori.
Ngan LT; Moon JK; Shibamoto T; Ahn YJ
J Agric Food Chem; 2012 Sep; 60(36):9062-73. PubMed ID: 22891951
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. pylori.
Rajinikanth PS; Mishra B
Acta Pharm; 2007 Dec; 57(4):413-27. PubMed ID: 18165186
[TBL] [Abstract][Full Text] [Related]
19. 3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.
Shi WK; Deng RC; Wang PF; Yue QQ; Liu Q; Ding KL; Yang MH; Zhang HY; Gong SH; Deng M; Liu WR; Feng QJ; Xiao ZP; Zhu HL
Bioorg Med Chem; 2016 Oct; 24(19):4519-4527. PubMed ID: 27492194
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity of Helicobacter pylori enhanced by acetohydroxamic acid.
von Wulffen H; Marquardt T
J Clin Pathol; 1994 Feb; 47(2):188-9. PubMed ID: 8132843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
